Brand Name(s): Epivir; Epivir-HBV
CAS nº: 134678-17-4
(la mih vue deen)
What is Lamivudine?
Lamivudine is an antiviral medication. It is in a group of human immunodeficiency virus (HIV) medicines called reverse transcriptase inhibitors. Lamivudine helps keep the HIV virus from reproducing in the body.
The Epivir® brand of lamivudine is used to treat HIV and hepatitis B viruses, which cause the acquired immunodeficiency syndrome (AIDS). On the other hand, the Epivir-HBV® brand of lamivudine is used to treat chronic hepatitis B.
Lamivudine is not, however, a cure for HIV or AIDS.
Latest News
Low-Dose Tenofovir Shows Efficacy in Patients With Lamivudine-Resistant Hepatitis B Virus: Presented at IM
Virologic breakthrough during hepatitis B virus (HBV) treatment with lamivudine is associated with...
[more]HIV/AIDS Update - Epivir Tablets for Pediatric Dosing
FDA has approved a new formulation of Epivir (lamivudine) designed to facilitate dosing in...
[more]Abacavir/Lamivudine Noninferior to Tenofovir/Emtricitabine as Backbone to Lopinavir/Ritonavir HIV Therapy: Presented at CROI
Doctors reported that the combination of the nucleoside reverse transcriptase inhibitors...
[more]What is the more suitable for early detection of low abundant lamivudine-resistant mutants?
Lamivudine is an effective antiviral agent for treatment of patients with chronic hepatitis B and...
[more]WHO Adds Three Ranbaxy Antiretrovirals to Prequalification List
Indian pharmaceutical company Ranbaxy Laboratories on Monday announced that the World Health...
[more]